These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1303085)

  • 21. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous leishmaniasis serodiagnosis by immunoperoxidase assay.
    Halevy D; Sarov B; Sarov I; el-On J
    Isr J Med Sci; 1990 Sep; 26(9):485-90. PubMed ID: 2228558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An indirect immunoperoxidase assay for rapid serodiagnosis of visceral leishmaniasis.
    Jain A; Agrawal M; Tiwari V
    Indian J Exp Biol; 1994 Nov; 32(11):822-5. PubMed ID: 7896312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antigens for the serodiagnosis of kala-azar and oriental sores by means of the indirect immunofluorescence antibody test (IFAT).
    Krampitz HE; Weiland G; Löscher T; Prüfer L
    Infection; 1981; 9(6):264-7. PubMed ID: 6174454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.
    Singh R; Subba Raju BV; Jain RK; Salotra P
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1191-4. PubMed ID: 16210482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani.
    Sivakumar R; Sharma P; Chang KP; Singh S
    Protein Expr Purif; 2006 Mar; 46(1):156-65. PubMed ID: 16172002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of rK39 strip test for the diagnosis of visceral leishmaniasis in infants.
    Alborzi A; Rasouli M; Nademi Z; Kadivar MR; Pourabbas B
    East Mediterr Health J; 2006; 12(3-4):294-9. PubMed ID: 17037697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Visceral leishmaniasis contracted in Europe (kala-azar)].
    Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
    Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune complex antigens as a tool in serodiagnosis of kala-azar.
    Chakraborti T; Sarkar D; Ghosh DK
    Mol Cell Biochem; 2003 Nov; 253(1-2):191-8. PubMed ID: 14619969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania donovani: isolation of a concanavalin-A specific antigen and its evaluation for serodiagnosis of visceral leishmaniasis.
    Bhattacharya M; Banerjee N; Ghosh DK
    Ann Trop Med Parasitol; 1992 Aug; 86(4):341-5. PubMed ID: 1281399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of prevalent status of kala-azar in endemic area of Hubei Province].
    Gui AF; Zuo SL; Wu JH; Gui XE; Hu LQ; Yang LD; Zhang SQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):170-2. PubMed ID: 12567700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis.
    Salam MA; Khan MG; Mondal D
    Trans R Soc Trop Med Hyg; 2011 May; 105(5):269-72. PubMed ID: 21353275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of excreted factors of Leishmania mexicana in serodiagnosis of kala-azar--a preliminary communication.
    Arora SK; Datta U; Sehgal S
    Indian J Med Res; 1985 Jun; 81():580-3. PubMed ID: 4054963
    [No Abstract]   [Full Text] [Related]  

  • 38. [The determination of the species specificity of Leishmania antibodies in different groups of human sera].
    Giboda M; Goncharov DB; Saf'ianova VM; Gracheva LI; Ditrich O
    Med Parazitol (Mosk); 1991; (3):29-32. PubMed ID: 1770880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.
    Ghedin E; Zhang WW; Charest H; Sundar S; Kenney RT; Matlashewski G
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):530-5. PubMed ID: 9302200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.